Construction of Pfizer-sponsored pharmaceutical factory starts in Russia
31 May 2017
A ground-breaking ceremony of a pharmaceutical factory was held on Tuesday in Vorsino technology park located near the Russian city of Kaluga. American company Pfizer is an investor of the enterprise's building project.
According to TASS news agency, the main partner of the project is NovaMedica, a portfolio company of the Russian government-owned company Rusnano engaged in the development of nanotechnology.
Speaking at the ceremony, Chairman of Rusnano’s Board Anatoly Chubais said that NovaMedica has barely started the construction of its factory, but it is already having the sales volume amounting to 1 billion rubles on the Russian market.
A third of medical drugs that will be manufactured at the enterprise under a license of Pfizer are not currently produced in the territory of Russia.
PrintShareholders
Pipeline
Media Center
-
27 January 2023
-
A child has been diagnosed with SMA in the neonatal screening that started in 2023
27 January 2023
-
Enhancing Clinical Trials with More Diverse Recruitment
26 January 2023
-
WHO pushes for action by manufacturers and governments after warnings over contaminated cough syrups
26 January 2023